课题基金 / 基金详情

HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccines

HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccines
HLA I 类肽组多样性和 CD8 T 细胞对 COVID-19 疫苗的反应
批准号:
10523733
负责人:
MALINI RAGHAVAN
金额:
$18.83万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-06-01 至 2024-05-31

项目摘要

项目成果

MALINI RAGHAVAN的其他基金

相似基金

相关文献

中文摘要
翻译
CD8+T细胞在主要组织相容性复合体I类(MHC-1)背景下识别短肽抗原 I)蛋白质。人类白细胞抗原(HLAA)、HLAB和HLAC三组基因编码 人类MHC-I(β-I)蛋白的重链,也包含轻链(HLA2-微球蛋白)和 多肽。HLAA、HLAB和HLAC基因具有高度的多态性。在细胞中,个别的人类白细胞抗原-I同种异型可以 可与许多来源于细胞内蛋白的多肽结合。细胞感染诱导特异性结合 病原体衍生的多肽,可触发CD8+T细胞识别和免疫。近期质量 光谱(MS)研究已经确定了数千个与人类白细胞抗原-I结合的多肽的序列 同种异型,个别的多肽。对这些肽序列的检查导致了变量假说 人类白细胞抗原-I同种异型之间的多肽谱系大小及其导致的CD8+T细胞反应广度的差异 到感染SARS-Cov2和接种新冠肺炎疫苗。为了解决这一假设,在拟议的研究中, 定量高分辨质谱学(MS)将被用来测量自身多肽的差异 选定的人类白细胞抗原-B同种异型的谱系大小。曲目大小变化背后的因素将是 检查过了。此外,诱导CD8+T细胞激活的SARS-CoV-2尖峰表位的广度将是 使用已接种COVID-19疫苗的精选HLA型献血者的血液进行测量, 检测在人类白细胞抗原-I同种异型之间表位宽度变化的流行率。总而言之,这些研究 解决不同的人类白细胞抗原-I型多肽多样性的流行和后果,重点是免疫 由新冠肺炎疫苗诱导。这些研究所产生的知识将为人类白细胞抗原的关键方面提供信息。 I生物学和疫苗诱导的免疫力。
英文摘要
CD8+ T cells recognize short peptide antigens in the context of major histocompatibility complex class I (MHC- I) proteins. Three sets of genes, the human leukocyte antigens (HLA) HLA-A, HLA-B and HLA-C encode the heavy chains of human MHC-I (HLA-I) proteins, which also contain a light chain (β2-microglobulin) and a peptide. The HLA-A, HLA-B and HLA-C genes are highly polymorphic. In cells, individual HLA-I allotypes can bind to many peptides derived from intracellular proteins. Cell infection induces the binding of specific pathogen-derived peptides, which can trigger CD8+ T cell recognition and immunity. Recent mass spectrometric (MS) studies have identified the sequences of thousands of peptides that bind to HLA-I allotypes, the individual peptidomes. Inspections of these peptide sequences lead to the hypothesis of variable peptide repertoire sizes among HLA-I allotypes and resulting variations in the breadth of CD8+ T cell responses to SARS-Cov2 infection and COVID-19 vaccination. To address this hypothesis, in the proposed studies, quantitative high resolution mass spectrometry (MS) will be used to measure differences in self-peptide repertoire sizes for selected HLA-B allotypes. Factors that underlie variations in repertoire sizes will be examined. Additionally, the breadth of SARS-CoV-2 Spike epitopes that induce CD8+ T cell activation will be measured using blood from select HLA genotyped blood donors who have been vaccinated against COVID-19, examining the prevalence of epitope breadth variations among HLA-I allotypes. Taken together, these studies address the prevalence and consequences of variable HLA-I peptidome diversities, with a focus on immunity induced by COVID-19 vaccines. The knowledge resulting from these studies will inform on key aspects of HLA- I biology and vaccine-indued immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccines
Peptide Repertoires of HLA class I molecules
Calreticulin-mediated protein folding in health and disease
Calreticulin-mediated protein folding in health and disease
海外基金